When you absolutely have to recruit patients on time.

Home -> Documents -> New Russian Drug Law: Clinical Studies and Marketing Authorization (2015)

New Russian Drug Law: Clinical Studies and Marketing Authorization (2015)

Dr. Natalia Nayanova, DIrector of Clinical Operations, gave a presentation “New Russian Drug Law: Changes Concerning Clinical Studies and Marketing Authorization and Their Implications” on October 22-23, 2015 at ‘Clinical Trials Innovation Programme’ in Frankfurt, Germany. Click on ‘view pdf’ link above to learn valuable insights.



From clinical research associates to hands-on founders, we fiercely pursue our strategic goal: deliver on schedule. We think of ourselves as your development partner, not a vendor.